Schedule 13D ownership disclosure

Therapeutics Acquisition Corp.

Security class unavailable · CUSIP: 88339T103

Event date: 2021-06-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,098,318
Percent of class
7.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-087621
Form type
SC 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Jun 30, 2021
Reporting period
Jun 24, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub